Why the study?
Does subclinical hypothyroidism affect noninvasive indicators of atherosclerosis such as FMD, CIMT, and aortic distensibility compared to controls?
Does subclinical hypothyroidism affect noninvasive indicators of atherosclerosis such as FMD, CIMT, and aortic distensibility compared to controls?
Subclinical hypothyroidism is associated with endothelial dysfunction as measured by reduced flow-mediated dilatation, though structural markers like CIMT remain unchanged.
Answers are grounded in this paper and cite their sources.
May indicate early endothelial dysfunction in subclinical hypothyroidism; leaves open effects on structural markers and need for intervention.
INTRODUCTION: Cardiovascular system is rich in thyroid hormone receptors and is one of the major sites of action for thyroid hormones. However, the effect of subclinical hypothyroidism (SCH) on atherosclerosis has not been cleared yet. MATERIALS AND METHODS: SCH is defined as high thyroid-stimulating hormone (TSH) levels in the presence of normal serum T4 and T3 levels. A total of 32 patients with SCH and 29 controls were included in the study. Carotid intima-media thickness, flow-mediated dilatation, and aortic distensibility were compared between the groups. RESULTS: FMD was lower in patients with SCH than in controls. GTN-induced vasodilatation was similar in the patients with SCH and controls. There was no statistically significant difference between the patients with SCH and controls with respect to CIMT and aortic distensibility. CONCLUSION: SCH is associated with endothelial dysfunction as established by FMD. Inconsistent results of CIMT and aortic stiffness can be explained by these parameters being measures of structural changes whereas FMD is a dynamic measure that reflects the impact of both acute and chronic influences on endothelial function.
No takes yet. Share an insight, caveat, or question.
Kilic et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: